These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 19199546)

  • 21. Epidemiology and natural history of genital human papillomavirus infection.
    Weaver BA
    J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S2-8. PubMed ID: 16729554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6/11/16/18) vaccine.
    Barthell E; Woelber L; Hellner K; Camerer B; Gieseking F; Hauschild M; Mylonas I; Friese K; Sings HL; Railkar R; Gause C; Barr E
    Arch Gynecol Obstet; 2009 Jun; 279(6):803-7. PubMed ID: 18936950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of high-risk human papillomavirus type 16/18 in cutaneous warts in immunocompetent patients, using polymerase chain reaction.
    Payal R; Gupta S; Aggarwal R; Handa S; Radotra BD; Arora SK
    Dermatol Online J; 2006 Oct; 12(6):1. PubMed ID: 17083881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What can surveillance of genital warts tell us?
    Fairley CK; Donovan B
    Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus infections and vulvar disease development.
    Garland SM; Insinga RP; Sings HL; Haupt RM; Joura EA
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1777-84. PubMed ID: 19505910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV).
    Aubin F; Prétet JL; Jacquard AC; Saunier M; Carcopino X; Jaroud F; Pradat P; Soubeyrand B; Leocmach Y; Mougin C; Riethmuller D;
    Clin Infect Dis; 2008 Sep; 47(5):610-5. PubMed ID: 18637758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses.
    David MP; Van Herck K; Hardt K; Tibaldi F; Dubin G; Descamps D; Van Damme P
    Gynecol Oncol; 2009 Dec; 115(3 Suppl):S1-6. PubMed ID: 19217149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacy.
    Lehtinen M; Idänpään-Heikkilä I; Lunnas T; Palmroth J; Barr E; Cacciatore R; Isaksson R; Kekki M; Koskela P; Kosunen E; Kuortti M; Lahti L; Liljamo T; Luostarinen T; Apter D; Pukkala E; Paavonen J
    Int J STD AIDS; 2006 Apr; 17(4):237-46. PubMed ID: 16595046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students.
    Partridge JM; Hughes JP; Feng Q; Winer RL; Weaver BA; Xi LF; Stern ME; Lee SK; O'Reilly SF; Hawes SE; Kiviat NB; Koutsky LA
    J Infect Dis; 2007 Oct; 196(8):1128-36. PubMed ID: 17955430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
    Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral and sociodemographic risk factors for serological and DNA evidence of HPV6, 11, 16, 18 infections.
    Wiley DJ; Masongsong EV; Lu S; Heather L S; Salem B; Giuliano AR; Ault KA; Haupt RM; Brown DR
    Cancer Epidemiol; 2012 Jun; 36(3):e183-9. PubMed ID: 22277329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and cost of treatment of genital warts in Spain.
    Castellsagué X; Cohet C; Puig-Tintoré LM; Acebes LO; Salinas J; San Martin M; Breitscheidel L; Rémy V
    Eur J Public Health; 2009 Jan; 19(1):106-10. PubMed ID: 19112075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine: a randomized, controlled trial in adolescent girls.
    Medina DM; Valencia A; de Velasquez A; Huang LM; Prymula R; García-Sicilia J; Rombo L; David MP; Descamps D; Hardt K; Dubin G;
    J Adolesc Health; 2010 May; 46(5):414-21. PubMed ID: 20413076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine.
    Giuliano AR; Lazcano-Ponce E; Villa L; Nolan T; Marchant C; Radley D; Golm G; McCarroll K; Yu J; Esser MT; Vuocolo SC; Barr E
    J Infect Dis; 2007 Oct; 196(8):1153-62. PubMed ID: 17955433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 108():2-32. PubMed ID: 19939209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine.
    Ault KA; Giuliano AR; Edwards RP; Tamms G; Kim LL; Smith JF; Jansen KU; Allende M; Taddeo FJ; Skulsky D; Barr E
    Vaccine; 2004 Aug; 22(23-24):3004-7. PubMed ID: 15297048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
    Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
    Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vaccination against HPV in adults].
    Gil Á
    Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():22-5. PubMed ID: 20084345
    [No Abstract]   [Full Text] [Related]  

  • 40. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
    Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.